Clinical Trials in Tennessee

Showing 14221-14240 of 20,239 trials

Obalon Balloon System Pivotal IDE (SMART) Trial

NCT02235870

This pivotal trial of the Obalon Balloon System is intended to generate safety and effectiveness data required to support a future marketing application. The trial has been designed to evaluate a 6-month use of the Obalon Balloon System as an adjunct to a nutrition and lifestyle behavior modification program. Weight loss will be evaluated after the 6-month course to determine if a specific predefined superiority margin can be achieved in the device group compared to a sham-control group.

Obesity

Obalon Therapeutics, Inc.711 participantsStarted Feb 2015

Scottsdale, Arizona, United States • Anaheim, California, United States • Coronado, California, United States +12 more locations

COMPLETED29 miles

Early Diagnosis of Pulmonary Nodules

NCT01752114

This study is intended to determine the positive predictive value (PPV) and negative predictive value (NPV) of the multiprotein classifier based on the observed study prevalence of Non-Small Cell Lung Cancer (NSCLC) in the study participants.

Precancerous ConditionsCarcinoma

Integrated Diagnostics684 participantsStarted Oct 2012

Phoenix, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +30 more locations

Obalon Balloon System Pivotal IDE (SMART) Trial

Early Diagnosis of Pulmonary Nodules

Find Trials by Condition in Tennessee

Third International Study on Mechanical Ventilation

A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer

Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

Investigating the Effect of Vortioxetine in Adult ADHD Patients

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial

Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

The Captivator EMR Registry

Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer

Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel

An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective